CBD Extracts are Target’s Loss and Lucky’s Market Gain

The latest cannabis news has more to do with hemp than it does marijuana. Lucky’s Market is selling hemp based CBD extracts nationwide. Cannabidiol, or CBD for short, is an active cannabinoid found in cannabis plants like marijuana and hemp. The medical marijuana industry is discovering that cannabidiol is the compound that connects to CB receptors within the endocannabinoid system and reduces pain and inflammation. Many researchers are working on refining techniques to pull CBD extracts from marijuana, however national retailers will not sell the products based from marijuana due to the fact that it is federally illegal.

However, national retailers may not need to worry about being in one of the recreational weed states to sell hemp-based CBD extracts. Whether hemp products are illegal federally is a different story. The DEA still wants to argue that even hemp-based CBD products are illegal, which was enough for Target to remove all CBD products from its shelves. The law is a little gray concerning hemp though, so Lucky’s Market jumped on the current popularity of cannabis and embraces the controversy of selling CBD extracts. Do you think that the DEA will raid Lucky’s Markets around the country, or is Target just paranoid?

For a brief moment last month, it appeared Target was on track to change the course of cannabidiol sales in the United States. But it turns out plucky Lucky’s Market is the national retailer disrupting the status quo.

The Colorado-based natural foods chain backed by grocery giant Kroger Co. is now selling nearly a dozen brands of hemp-derived extracts rich in the cannabis compound known as CBD at its 25 stores across the nation.

“We’re not afraid to be disruptive and pave the path and be pioneers,” said Sindy Wise, Lucky’s director of apothecary.

The move is risky in the American retail market where the legality of such extracts has been called into question by the U.S. Drug Enforcement Administration.

In late September, quietly began selling a selection of CBD oils made by Denver’s CW Hemp. The decision for the multinational retailer to sell CBD was viewed as bold — perhaps even a challenge to the government entities and others questioning the legality of hemp-derived extracts.

But Target pulled the products and the companies clammed up after The Cannabist reported that CBD items were available to purchase on Aside from Target releasing a brief statement confirming the products’ removal, neither the retailer nor CW Hemp returned multiple calls and emails seeking comment.

Taking a potentially “revolutionary” leap was a no-brainer for Lucky’s, Wise said. And after conferring closely with lawyers for the U.S. Food and Drug Administration, the retailer won’t be changing its mind.

Lucky’s founder Bo Sharon advocates for “positive disruption,” and that includes staying ahead of trends in the natural products industry and responding to consumer requests, she said.

“Customers are trying to find these solutions and trying to find these products,” she said, adding that Lucky’s role involves serving as a provider of quality sourced products in addition to educator.

And considering hemp-derived extracts, she added, the role extends to that of stigma-breaker.

“This is the next big thing in terms of natural medicine,” she said.

Lucky’s went big with the Sept. 27 launch, touting CBD oils and adaptogenic plants — natural substances that promote biological balance and help the body adapt to stress — in its October magazine, and dedicating two full shelving displays in the Apothecary section of its stores to a line of private-label hemp oils, salves and body butters, as well as the products of a handful of other manufacturers. The products are marketed alongside reishi and shiitake mushrooms, holy basil (tulsi), rhodiola, ginseng and licorice.

But the chain also was calculating — offering hemp-extract products made into topicals that are applied to the skin, as well as consumable powders and capsules.

Lucky’s has had hemp extracts in its sights for more than a year, and Wise bore witness to the products’ legal and regulatory rollercoaster ride.

The CBD extract industry, already booming, got a nice bump after voters in eight more states sought to legalize medical or recreational marijuana last November. Then came the chill: The U.S. Drug Enforcement Administration moved forward on new drug-code regulations for cannabis extracts, in the process reaffirming its position that CBD-rich extracts — even those derived from hemp — are Schedule I controlled substances.

Wise and Lucky’s paused, but then went full speed ahead after seeing hemp companies marketing their products at the Natural Products Expo West, the natural and organic industry’s largest trade show. Lucky’s struck up conversations with vendors and checked with FDA lawyers to ensure that labeling and other standards were being met, Wise said.

Lucky’s moved fast and went big to have the products launch before the holidays and before next year, when the Niwot, Colo.-based grocer is expected to open another 20 stores.

“It is legal, otherwise we wouldn’t sell it,” Wise said.

Others, including DEA officials, have disagreed, claiming that the extracts derived from industrial hemp operations allowed under federal and state laws remain illicit.

Hemp industry members have challenged that interpretation by taking the DEA to court.

“We disagree with (the DEA’s) position and feel that CBD and whole-plant extracts from hemp (pursuant to the 2014 Farm Bill, hemp amendment and state industrial hemp pilot program regulations) are fully lawful,” said Patrick Goggin, an attorney with Denver-based Hoban Law Group, who is representing the hemp industry members in their legal petitions.

That the retailer is trading in something taboo is not lost on Wise and Lucky’s officials.

“It’s something that is right and that something is what consumers want,” Wise said. “It is a risk. And it is definitely putting ourselves out there.”

Read more…

Show More

Richard Lowe

Richard Lowe is a 14-year veteran of the financial sector with licenses as a commodity broker (Series 3) and investment advisor representative (IAR Series 65). Along with a focus on raising capital for the firms he was employed with, he also wrote and edited much of the content published by them. He holds a BA in Journalism from the University of Massachusetts. He has been a longtime advocate for marijuana legalization due to the social injustices associated with marijuana prohibition and the strong potential for the medicinal benefits of cannabis.

Related Articles

Leave a Reply

Back to top button